A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

N/ACompletedNCT00203008

Teva Branded Pharmaceutical Products R&D, Inc.2,106 enrolled

Overview

Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions.

Study Type

OBSERVATIONAL

Enrollment

2,106

Conditions

Parkinson's Disease Malignant Melanoma

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment Exclusion Criteria: unconfirmed, undocumented Parkinson's disease unable to give consent taking any investigational product

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.